FindTrial
Sign In

Optimization of oral fat tolerance test and the effects of ApoB differential expression on postprandial hypertriglyceridemia

Optimization of oral fat tolerance test and the effects of ApoB differential expression on postprandial hypertriglyceridemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048497
Enrollment
Unknown
Registered
2021-07-09
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipids metabolism disorder

Interventions

Group 1:Fixed-calorie oral fat tolerance
Group 2:Calories in kg body weight Oral fat tolerance

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Healthy adults; 2. Patients with special metabolic diseases: carotid atherosclerosis, non-alcoholic fatty liver disease, impaired glucose tolerance.

Exclusion criteria

Exclusion criteria: 1. Vegetarians, malignant tumors, hyperlipidemia, diabetes, heart disease, thyroid dysfunction, kidney disease, acute and chronic blood diseases, infectious diseases, mental disorders; 2. Stroke and pregnancy within the past 3 months; 3. Taking related drugs that affect glucose and lipid metabolism (fish oil, contraceptives, hormones, beta-blockers, diuretics); 4. Severe infection, surgery, trauma history, weight change over 3kg.

Design outcomes

Primary

MeasureTime frame
fasting glucose;fasting insulin;fasting total cholesterol;fasting LDL cholesterol;fasting HDL cholesterol;fasting apolipoproteins;postprandial triglyceride;postprandial blood glucose;postprandial insulin;—

Countries

China

Contacts

Public ContactSong Guangyao

Hebei General Hospital

sguangyao2@163.com+86 13930119808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026